SecuritySLDA / Sutherland Asset Management Corp (86933G105)
CEO, President and DirectorSzymanski Michael
IndustryReal Estate Investment Trusts
Institutional Owners73
Institutional Shares10,539,591 - 32.88%
Common Shares Outstanding32,051,989 shares (as of 2018-06-30)
Institutional Value$ 377,274,000 USD
Related SLD / Sutherland Assest Management Corp.
ZFC / ZAIS Financial Corp.

Institutional Stock Ownership and Shareholders

Sutherland Asset Management Corp (NYSE:SLDA) has 73 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,539,591 shares. Largest shareholders include Farallon Capital Management Llc, American Financial Group Inc, BlackRock Inc., Vanguard Group Inc, Raymond James & Associates, Tcw Group Inc, State Street Corp, West Family Investments, Inc., Northern Trust Corp, and BlackRock Institutional Trust Company, N.A..
Sutherland Asset Management Corp (NYSE:SLDA) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 187,326 2,520
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 20,883 22,789 9.13 316 370 17.09
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 79,778 121,373 52.14 1,209 1,972 63.11
2018-08-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 1,800 1,800 0.00 27 29 7.41
2018-08-06 13F-HR RHUMBLINE ADVISERS 14,414 16,999 17.93 218 276 26.61
2018-08-02 13F-HR Orinda Asset Management LLC 20,000 0 -100.00 303 0 -100.00
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 18,100 18,100 0.00 274 294 7.30
2017-02-10 13F-HR BlackRock Investment Management, LLC 1,961 26
2018-08-13 13F-HR BB&T SECURITIES, LLC 40,896 36,996 -9.54 619 601 -2.91
2018-07-24 13F-HR MEEDER ASSET MANAGEMENT INC 2,282 5,919 159.38 35 96,185 274,714.29
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 11,241 11,510 2.39 170 187 10.00
2018-08-14 13F-HR VANGUARD GROUP INC 807,018 818,444 1.42 12,226 13,300 8.78
2018-08-14 13F-HR CREDIT SUISSE AG/ 17,055 15,000 -12.05 258 243 -5.81
2018-08-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 6,167 6,167 0.00 93,430 100,214 7.26
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 16,370 266
2018-09-18 13F-HR/A NORTHERN TRUST CORP 198,596 208,988 5.23 3,009 3,396 12.86
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 3,951 674 -82.94 59,858 10,952 -81.70
2018-08-15 13F-HR Metlife Investment Advisors, Llc 8,791 8,791 0.00 133 143 7.52
2018-08-10 13F-HR AMERICAN FINANCIAL GROUP INC 1,480,212 1,480,212 0.00 22,425 24,053 7.26
2018-07-24 13F-HR ACADIAN ASSET MANAGEMENT LLC 0 51,887 0 844
2018-08-14 13F-HR MORGAN STANLEY 65,623 62,238 -5.16 995 1,012 1.71
2018-08-13 13F-HR Hillsdale Investment Management Inc. 320 280 -12.50 5 5 0.00
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 40,841 38,358 -6.08 619 623 0.65
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 26,685 29,286 9.75 404 476 17.82
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 14,979 15,081 0.68 227 245 7.93
2018-08-10 13F-HR CITIGROUP INC 6,937 5,518 -20.46 104 89 -14.42
2018-08-13 13F-HR Allianz Asset Management AG 68,563 89,739 30.89 1,038 1,458 40.46
2018-08-14 13F-HR UBS Group AG 7,252 2,985 -58.84 110 49 -55.45
2018-07-20 13F-HR North Star Investment Management Corp. 309 309 0.00 5 5 0.00
2018-08-03 13F-HR VIRGINIA RETIREMENT SYSTEMS ET AL 23,900 11,100 -53.56 362 180 -50.28
2018-08-14 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 56,311 0 -100.00 853 0 -100.00
2018-08-09 13F-HR MARTINGALE ASSET MANAGEMENT L P 24,218 394
2018-08-14 13F-HR FARALLON CAPITAL MANAGEMENT LLC 2,208,239 2,208,239 0.00 33,455 35,884 7.26
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 26,133 26,133 0.00 396 396 0.00
2018-02-12 13F-HR Hutchin Hill Capital, LP 17,300 17,300 0.00 272 262 -3.68
2018-08-13 13F-HR Archford Capital Strategies, LLC 217 0 -100.00 3 0 -100.00
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 113,255 149,510 32.01 1,715 2,428 41.57
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 11,966 194
2017-02-10 13F-HR BlackRock Fund Advisors 167,774 2,257
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 11,829 8,961 -24.25 180 145 -19.44
2018-08-08 13F-HR Russell Investments Group, Ltd. 0 1,754 0 29
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 27,105 27,105 0.00 411 440 7.06
2018-08-07 13F-HR Quad-cities Investment Group, Llc 362 6
2018-07-30 13F-HR State of New Jersey Common Pension Fund D 139,000 139,000 0.00 2,106 2,259 7.26
2018-08-06 13F-HR STRS OHIO 4,900 4,900 0.00 74 79 6.76
2018-08-14 13F-HR JP Morgan Chase & Co 59,247 60,448 2.03 898 982 9.35
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 307 5
2018-08-02 13F-HR FIRST TRUST ADVISORS LP 15,059 17,768 17.99 228 289 26.75
2018-08-14 13F-HR BALYASNY ASSET MANAGEMENT LLC 19,775 12,675 -35.90 300 206 -31.33
2018-08-13 13F-HR OXFORD ASSET MANAGEMENT 0 33,658 0 547
2018-08-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 26,808 28,527 6.41 406 464 14.29
2018-07-19 13F-HR Legacy Advisors, Llc 270 4
2017-11-09 13F-HR TFS CAPITAL LLC 15,757 0 -100.00 234 0 -100.00
2018-08-01 13F-HR ASSETMARK, INC 9,715 15,852 63.17 147 258 75.51
2018-07-19 13F-HR HARTFORD INVESTMENT MANAGEMENT CO 19,460 316
2018-08-09 13F-HR West Family Investments, Inc. 410,322 410,322 0.00 6,216 6,668 7.27
2018-08-13 13F-HR Renaissance Technologies LLC 67,400 1,021
2018-08-14 13F-HR STATE STREET CORP 448,829 497,611 10.87 6,800 8,085 18.90
2018-08-14 13F-HR DEUTSCHE BANK AG\ 19,704 92,724 370.58 296 1,504 408.11
2018-07-27 13F-HR Eqis Capital Management, Inc. 29,831 0 -100.00 452 0 -100.00
2018-08-01 13F-HR TCW GROUP INC 466,525 532,525 14.15 7,068 8,654 22.44
2018-08-14 13F-HR PANAGORA ASSET MANAGEMENT INC 32,179 9,860 -69.36 488 160 -67.21
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 1,486 1,486 0.00 23 24 4.35
2018-08-14 13F-HR Marshall Wace North America L.P. 37,705 613
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 735,169 699,469 -4.86 11,138 11,366 2.05
2018-08-10 13F-HR Legal & General Group Plc 3,322 2,635 -20.68 50 43 -14.00
2018-08-13 13F-HR Varma Mutual Pension Insurance Co 77,283 77,283 0.00 1,170 1,253 7.09
2018-08-14 13F-HR TEACHERS ADVISORS INC 32,144 37,183 15.68 487 604 24.02
2018-08-14 13F-HR ROYAL BANK OF CANADA 9,025 9,063 0.42 136 148 8.82
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 147,691 145,010 -1.82 2,237 2,357 5.36
2018-08-09 13F-HR BlackRock Inc. 1,386,551 1,470,669 6.07 21,005 23,898 13.77
2018-08-14 13F-HR BARCLAYS PLC 3,666 1,293 -64.73 56 21 -62.50
2018-08-13 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 6,573 0 -100.00 100 0 -100.00
2018-08-14 13F-HR Invesco Ltd. 44,225 53,591 21.18 670 871 30.00
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 125 2
2018-05-11 13F-HR CITIGROUP INC 11,121 6,937 -37.62 168 104 -38.10
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 39,800 39,800 0.00 603 647 7.30
2018-08-14 13F-HR QS Investors, LLC 28 28 0.00 1 1 0.00
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 0 55,085 0 895
2018-08-09 13F-HR Swiss National Bank 29,400 29,400 0.00 445 478 7.42

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Annaly (NLY) to Make Public Offering of 75M Common Stock

2018-09-12 zacks
Annaly Capital Management, Inc. (NLY - Free Report) recently discussed its plans to make a public offering of 75 million shares of common stock. Also, the company is giving underwriters a 30-day option to purchase up to an additional 11,250,000 shares. Annaly plans spend the proceeds for targeted asset acquisitions under its capital-allocation policy. It will also be used for general corporate purposes, which may include trimming the company’s liabilities and working capital items. (3-1)

Top Ranked Momentum Stocks to Buy for September 10th

2018-09-10 zacks
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 10th: (4-0)

Markets Face Multiple Risks in September: 6 Defensive Picks

2018-09-04 zacks
U.S. markets ended August on a strong note with most indexes hovering around record levels. Additionally, major benchmarks provided positive returns over the last four months, barring a small fluctuation by the Dow in June. The economy remains robust and earnings results have remained consistently strong. (1-0)

Top Ranked Value Stocks to Buy for August 29th

2018-08-29 zacks
Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 29th:

38 'Safer' Dividend Dogs Of 114 Russell WallStars Tagged For August

2018-08-29 seekingalpha
38 of 114 Russell 3000 stocks were called "safer" for dividends by showing positive one-year returns and free cash flow yields greater than dividend yields. (21-1)

CUSIP: 86933G105